A personalized plan, based on your medical history and goals, gives you the safest and most effective path forward
doi:10.1080/09513590.2019.1681959 Muscogiuri G, Altieri B, de Angelis C, et al
Newport Beach, Irvine, and Costa Mesa patients receive a tirzepatide protocol calibrated to their physiology, comorbidities, and longevity goals guided by lab work, not assumptions
ASHP continues to oppose this rebate program, which forces providers to carry additional costs, putting patient access at risk
Last August, North Carolina became the latest state to begin covering some federal Food and Drug Administration-approved GLP-1s for obesity treatment among some populations, joining a dozen other states
PubMed CrossRef Probst L, Monnerat S, Vogt DR, et al